[1] Elomaa A, Advani A, Donnelly D, et al. Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories. Vaccine, 2007; 25, 918−26. doi:  10.1016/j.vaccine.2006.09.012
[2] Barkoff AM, Mertsola J, Pierard D, et al. Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015. Euro Surveill, 2019; 24, 1700832.
[3] Xu J, Chen YQ, Yue MM, et al. Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in China, 2010-2020: a systematic review and meta-analysis. Hum Vaccin Immunother, 2022; 18, 2071077. doi:  10.1080/21645515.2022.2071077
[4] Kügler S, Böcker K, Heusipp G, et al. Pertussis toxin transiently affects barrier integrity, organelle organization and transmigration of monocytes in a human brain microvascular endothelial cell barrier model. Cell Microbiol, 2007; 9, 619−32. doi:  10.1111/j.1462-5822.2006.00813.x
[5] Zhang HY, Wang X, Xia H, et al. Metagenomics next-generation sequencing assists in the diagnosis of infant pertussis encephalopathy: a case report. Medicine, 2023; 102, e33080. doi:  10.1097/MD.0000000000033080
[6] Chen YH, Mao LF, Lai DM, et al. Improved targeting of the 16S rDNA nanopore sequencing method enables rapid pathogen identification in bacterial pneumonia in children. Front Cell Infect Microbiol, 2023; 12, 1001607. doi:  10.3389/fcimb.2022.1001607
[7] Le T, Cherry JD, Chang SJ, et al. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. J Infect Dis, 2004; 190, 535−44. doi:  10.1086/422035
[8] Zhang ZJZ, Pan JB, Chen M, et al. Seroepidemiology of pertussis in China: a population-based, cross-sectional study. Vaccine, 2021; 39, 1687−92. doi:  10.1016/j.vaccine.2021.02.032
[9] Vidor E, Plotkin SA. Immunogenicity of a two-component (PT&FHA) acellular pertussis vaccine in various combinations. Hum Vaccin, 2008; 4, 328−40. doi:  10.4161/hv.4.5.6008
[10] He F, Xia X, Nie DW, et al. Respiratory bacterial pathogen spectrum among COVID-19 infected and non–COVID-19 virus infected pneumonia patients. Diagn Microbiol Infect Dis, 2020; 98, 115199. doi:  10.1016/j.diagmicrobio.2020.115199